Abstract
Transient loss of consciousness (T-LOC) is a common clinical presentation. However, since syncope is only one of several explanations for T-LOC, and it is often unclear whether other causes have been adequately excluded, estimates of the frequency of syncope based on T-LOC occurrences can only be considered an approximation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Chen LY, et al. Prevalence of syncope in a population aged more than 5 years. Am J Med. 2006;119(1088):e2.
Sheldon RS, Serletis A. Epidemiological aspects of transient loss of consciousness/syncope. In: Benditt DG, et al (eds). Syncope and Transient Loss of Consciousness. A multidisciplinary approach. Oxford: Blackwell Publishing;2007:pp 8–14.
Savage DD, et al. Epidemiologic features of isolated syncope: the Framingham Study. Stroke. 1985;16:626–629.
Soteriades ES, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878–885.
Ganzeboom KS, et al. Prevalence and triggers of syncope in medical students. Am J Cardiol. 2003;91:1006–1008.
Serletis A, et al. Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J. 2006;27:1965–1970.
Colivicchi F, et al. Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J. 2004;25:1749–1753.
Lipsitz LA, et al. Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. Q J Med. 1985;55:45–54.
Kenny RA, et al. Impact of a dedicated syncope and falls facility for older adults on emergency beds. Age Ageing. 2002;31:272–275.
Kenny RAM, et al. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol. 2001;38:1491–1496.
Cherin P, et al. Risk of syncope in the elderly and consumption of drugs: A case control study. J Clin Epidemiol. 1997;50:313–320.
Lewis DA, Dhala A. Syncope in the pediatric patient. The cardiologist’s perspective. Pediatr Clin North Am. 1999;46:205–219.
Murdoch BD. Loss of consciousness in healthy South African men: incidence, causes, and relationship to EEG abnormality. S Afr Med J. 1980;57:771–774.
Dermkasian G, Lamb I. Syncope in a population of healthy young adults: incidence, mechanisms, and significance. JAMA. 1958;168:1200–1207.
Feruglio GA, Perraro F. Rilievi epidemiologici sulla sincope nella popolazione generale e come causa di ricovero. G Ital Cardiol. 1987;17(suppl I):11–13.
Sheldon R, et al. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation. 1996;93:973–981.
Middlekauff H, et al. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 1993;21:110–116.
Martin TP, et al. Risk stratification of patients with syncope. Ann Emerg Med. 1997;29: 459–466.
Kapoor WN, et al. Diagnostic and prognostic implications of recurrences in patients with syncope. Am J Med. 1987;83:700–708.
Pires LA, et al. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators. Am J Cardiol. 2000;85:725–728.
Olshansky B, et al. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. Am Heart J. 1999;137:878–886.
Steinberg JS, et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol. 2001;12:996–1001.
Knight BP, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 1999;33: 1964–1970.
Olshansky B, et al. Syncope predicts the outcome of cardiomyopathy patients: Analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008;51:1277–1282.
Spirito P, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119:1703–1710.
Sauer AJ, et al. Long QT syndrome in adults. J Am Coll Cardiol. 2007;49:329–337.
Sacher F, et al Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome. A Multicenter Study. Circulation. 2006;114:2317–2324.
Sarkozy A, et al Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J. 2007;28:334–344.
Paul M, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2006;28:2126–2133.
Olde Nordkamp LRA, et al. Syncope prevalence in the ED compared to general practice and population: a strong selection process. Am J Emerg Med. 2009;27:271–278.
Malasana G, Brignole M, Daccaret M, Sherwood R, Hamdan M. The magnitude of the Faint and Fall Problem in the general population of Utah: a first step towards the creation of a cost-effective diagnostic approach. Pacing Clin Electrophysiol. 2010, Oct 4. doi: 10.1111/j.1540-8159.2010.02930.x. [Epub ahead if print].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Brignole, M., Benditt, D.G. (2011). Epidemiology of Syncope (Fainting). In: Syncope. Springer, London. https://doi.org/10.1007/978-0-85729-201-8_3
Download citation
DOI: https://doi.org/10.1007/978-0-85729-201-8_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-200-1
Online ISBN: 978-0-85729-201-8
eBook Packages: MedicineMedicine (R0)